Image credit: Alyson Martin

Jamaica’s Big Bet on Cannabis Research Partnerships

The country is partnering with Harvard to research and develop “high-quality” strains of medical cannabis, aiming to "transform and diversify the Jamaican national economy.”

Caribbean
CBD

In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

The DEA has taken Epidiolex, a CBD-based formula for rare forms of epilepsy, completely off its list of controlled substances. Why? The 2018 Farm Bill.

Lobbying

The Cannabis Industry Spent More On Lobbying Than Ever Before in 2019. What’s Next is Unclear.

Companies and organizations spent nearly $11 million on federal lobbying alone, vastly outpacing previous years. But given the coronavirus, 2020 is a mystery.

Newsletter

Canada: medical cannabis is essential • Canopy’s board transformation • Australia’s cannabis access review • & more…

An excerpt from recent editions of the Cannabis Wire Daily newsletter.